Similarly, Glycodelin, a glycoprotein involved in immune modulation and cancer cell survival, was examined in a study where the combination of Glycodelin, CA‐125, and HE4 led to an improved AUC of 0.987 in an RNN model [131]. This evidence concerns the gene WFDC2 and cancer.